A 62-year-old woman with rheumatoid arthritis on methotrexate and adalimumab presents with a 5-day history of progressive right hip pain, fever (38.8°C), and inability to weight-bear. She denies recent joint injections or trauma. Hip aspiration yields cloudy fluid: WBC 42,000/μL (88% neutrophils), glucose 22 mg/dL (serum 105 mg/dL), protein 5.8 g/dL. Gram stain is negative. Blood cultures and synovial culture are sent. Which organism is most likely responsible, and what is the most appropriate initial antibiotic regimen?

Explanation

## Diagnosis: Septic Arthritis in Immunosuppressed Host ### Clinical Context **Key Point:** Immunosuppression (TNF-α inhibitor + methotrexate) increases risk of both common organisms (*S. aureus*) and atypical pathogens (TB, fungal). However, the acute presentation (5 days, fever, high synovial WBC with low glucose) is classic for acute bacterial septic arthritis, most commonly *S. aureus*. **High-Yield:** In RA patients on biologics: - *S. aureus* remains the most common cause of acute septic arthritis (40–50%) - Gram-negative organisms and TB are more frequent than in immunocompetent hosts - Negative Gram stain does NOT exclude *S. aureus* (sensitivity ~60%) ### Why *Staphylococcus aureus*? | Feature | Finding | Significance | |---------|---------|-------------| | Onset | Acute (5 days) | Bacterial, not TB (insidious over weeks) | | Fever | 38.8°C | Acute infection | | Synovial WBC | 42,000/μL | Consistent with acute bacterial arthritis | | Glucose ratio | 22/105 (21%) | <50% = bacterial (TB typically >50%) | | Gram stain | Negative | *S. aureus* can be Gram-stain negative in 40% of cases | | Culture status | Pending | Empirical therapy must cover *S. aureus* | ### Empirical Antibiotic Choice **High-Yield:** In immunosuppressed patients with suspected septic arthritis and negative Gram stain, cover both MSSA and MRSA: ```mermaid flowchart TD A[Septic arthritis<br/>Immunosuppressed host<br/>Gram stain negative]:::outcome --> B{MRSA risk?}:::decision B -->|High risk<br/>Healthcare exposure<br/>Prior MRSA| C[IV vancomycin<br/>+ ceftriaxone or cefepime]:::action B -->|Low risk<br/>Community-acquired| D[IV cefazolin<br/>+ gentamicin]:::action C --> E[Adjust at 48-72 hrs<br/>based on culture]:::action D --> E E --> F[Surgical drainage<br/>within 24 hours]:::action ``` **Rationale for vancomycin + ceftriaxone:** - **Vancomycin:** Covers MRSA (risk increased in immunosuppressed, healthcare-exposed patients) - **Ceftriaxone:** Covers gram-negative organisms (*Enterobacteriaceae*, *Pseudomonas*) and *Streptococcus* species; achieves good synovial penetration - **Gentamicin** is an alternative to ceftriaxone for gram-negative coverage but has lower synovial penetration **Clinical Pearl:** Immunosuppressed patients have higher rates of MRSA and gram-negative septic arthritis. Vancomycin is safer than assuming MSSA in this population. ## Why Not the Other Organisms? | Organism | Why Not | |----------|----------| | *M. tuberculosis* | Insidious onset (weeks to months), not acute (5 days). Synovial glucose typically >50% of serum in TB. Requires prolonged multi-drug therapy, not acute empirical coverage. | | *S. pneumoniae* | Rare cause of septic arthritis in adults. Ceftriaxone monotherapy is inadequate if MRSA is possible. | | *N. gonorrhoeae* | Typically causes migratory polyarthritis, not monoarticular hip arthritis. Rare in post-menopausal women. | [cite:Robbins 10e Ch 26; Harrison 21e Ch 330]